{"entity":{"id":"iaso-bio","kind":"company","name":"IASO Biotherapeutics","aka":["驯鹿生物","IASO Bio"],"tldr":"IASO Bio developed eque-cel, the fully human BCMA CAR-T for myeloma approved in China in 2023 and partnered with Innovent.","summary":"IASO Biotherapeutics, based in Nanjing and Shanghai and founded in 2017, developed equecabtagene autoleucel, or eque-cel, the fully human BCMA CAR-T for multiple myeloma approved in China in 2023 and partnered with Innovent. The work was spun out of Tongji Hospital in Wuhan, eque-cel, sold as Fucaso, was approved in June 2023 on the FUMANBA-1 trial and holds FDA RMAT designation, and the pipeline includes CD19 and BCMA CAR-Ts for autoimmune disease and a CD19 and BCMA dual CAR-T. OnCo links it to CAR-T cell therapy, to the eque-cel record, to Innovent Biologics and to Tongji Hospital. Whether a Chinese-developed CAR-T can win approval in the United States on its own data is the open question. Equecabtagene autoleucel has its own page.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://www.iasobio.com/"}],"tags":["china"],"related":[],"cancers":[],"sections":["cell-therapy"],"technologies":["car-t"],"targets":[],"drugs":["equecabtagene-autoleucel"],"companies":["innovent"],"institutions":["tongji-hospital-wuhan"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Nanjing / Shanghai","country":"CN","companyType":"cell-therapy","website":"https://www.iasobio.com/","founded":2017,"investors":[],"funding":[]},"route":"/companies/iaso-bio/","neighbours":{"section":[{"id":"cell-therapy","kind":"section","name":"Cell Therapy","route":"/fronts/cell-therapy/"}],"technology":[{"id":"car-t","kind":"technology","name":"CAR-T cell therapy","route":"/technologies/car-t/"}],"drug":[{"id":"equecabtagene-autoleucel","kind":"drug","name":"Equecabtagene autoleucel","route":"/drugs/equecabtagene-autoleucel/"}],"company":[{"id":"innovent","kind":"company","name":"Innovent Biologics","route":"/companies/innovent/"}],"institution":[{"id":"tongji-hospital-wuhan","kind":"institution","name":"Tongji Hospital, Huazhong University of Science and Technology","route":"/institutions/tongji-hospital-wuhan/"}],"trial":[{"id":"fumanba-1","kind":"trial","name":"FUMANBA-1","route":"/trials/fumanba-1/"}]}}